Boundless Bio, Inc.

NasdaqGS:BOLD

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 23.95 M

Share Price

USD 1.07

Avg Daily Volume

74,090

Change (1 day)

0.94%

Change (1 year)

Change (YTD)

-51.80%

Boundless Bio, Inc. Total Assets for the year ending December 31, 2022: USD 76.83 M

Boundless Bio, Inc. Total Assets is USD 76.83 M for the year ending December 31, 2022, a -32.44% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Boundless Bio, Inc. Total Assets for the year ending December 31, 2021 was USD 113.72 M.

Competitors

AbbVie Inc.

USD 189.28

ABBV

-1.47 -0.77%

Novo Nordisk A/S

USD 68.84

NOVO-B.CO

-0.79 -1.13%

Roche Holding AG

USD 344.49

RO.SW

-3.19 -0.92%

Novartis AG

USD 121.35

NOVN.SW

-2.55 -2.06%

Abbott Laboratories

USD 134.44

ABT

+0.33 0.25%

AstraZeneca PLC

USD 139.36

AZN.L

-2.26 -1.60%

Merck & Co., Inc.

USD 80.96

MRK

-1.43 -1.74%

Amgen Inc.

USD 298.52

AMGN

+1.67 0.56%

Pfizer Inc.

USD 25.39

PFE

+0.07 0.30%

Gilead Sciences, Inc.

USD 111.75

GILD

+0.24 0.21%

Sanofi

USD 96.95

SAN.PA

-1.69 -1.71%

Vertex Pharmaceuticals Incorporated

USD 459.62

VRTX

+2.59 0.57%

Bristol-Myers Squibb Company

USD 46.92

BMY

-0.71 -1.49%

Chugai Pharmaceutical Co., Ltd.

USD 48.89

4519.T

+0.35 0.72%

GSK plc

USD 19.04

GSK.L

-0.17 -0.91%

CSL Limited

USD 158.35

CSL.AX

+0.51 0.32%

Regeneron Pharmaceuticals, Inc.

USD 547.36

REGN

-0.38 -0.07%

MERCK Kommanditgesellschaft auf Aktien

USD 130.20

MRK.DE

-2.77 -2.08%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.47

600276.SS

+0.15 2.03%

Takeda Pharmaceutical Company Limited

USD 30.58

4502.T

+0.07 0.24%

Key Data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt